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Abstract
Introduction: Iron deficiency is highly prevalent in pre-school children in developing countries and an important health
problem in sub-Saharan Africa. A debate exists on the possible protective effect of iron deficiency against malaria and other
infections; yet consensus is lacking due to limited data. Recent studies have focused on the risks of iron supplementation
but the effect of an individual’s iron status on malaria risk remains unclear. Studies of iron status in areas with a high burden
of infections often are exposed to bias. The aim of this study was to assess the predictive value of baseline iron status for
malaria risk explicitly taking potential biases into account.
Methods and materials: We prospectively assessed the relationship between baseline iron deficiency (serum ferritin
,30 mg/L) and malaria risk in a cohort of 727 Malawian preschool children during a year of follow-up. Data were analyzed
using marginal structural Cox regression models and confounders were selected using causal graph theory. Sensitivity of
results to bias resulting from misclassification of iron status by concurrent inflammation and to bias from unmeasured
confounding were assessed using modern causal inference methods.
Results and Conclusions: The overall incidence of malaria parasitemia and clinical malaria was 1.9 (95% CI 1.8–2.0) and 0.7
(95% CI 0.6–0.8) events per person-year, respectively. Children with iron deficiency at baseline had a lower incidence of
malaria parasitemia and clinical malaria during a year of follow-up; adjusted hazard ratio’s 0.55 (95%-CI:0.41–0.74) and 0.49
(95%-CI:0.33–0.73), respectively. Our results suggest that iron deficiency protects against malaria parasitemia and clinical
malaria in young children. Therefore the clinical importance of treating iron deficiency in a pre-school child should be
weighed carefully against potential harms. In malaria endemic areas treatment of iron deficiency in children requires
sustained prevention of malaria.
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Introduction
Childhood iron deficiency is prevalent globally with highest
estimates in children in developing countries. In sub-Saharan
Africa, 33–66% of children are iron deficient, most of whom are
under the age of five years [1,2]. The high prevalence of iron
deficiency in these populations is a consequence of low nutritional
iron intake due to low economic status [2], decreased absorption of
dietary iron due to a high prevalence of infections [3] or intestinal
blood loss in the case of helminth infections [4]. Iron deficiency
causes anemia and developmental dysfunction [2,3] and the
current consensus is to treat all iron deficient children [5].
Conversely, evidence of a protective effect of iron deficiency
against malaria and other infections exists [6–12].
In recent years concerns have focused mainly on the possible
harmful effects of treating iron deficiency rather than on the effects
of iron status itself [13–19]. A recent Cochrane meta-analysis
reviewing iron supplementation in children in malaria endemic
areas concluded that iron supplementation did not adversely effect
children in malaria endemic areas when adequate malaria
surveillance is provided, although the authors considered their
data were limited by various factors including lack of data on
baseline iron status [20]. There is little conclusive data on the
protective effect of iron deficiency against malaria. The reliability
of current data on iron status is limited since available iron
biomarkers are affected by inflammation which makes interpre-
tation of results from malaria endemic areas problematic [21]. In
addition, the complexity of factors influencing both malaria
susceptibility and iron status are not always taken into account,
potentially leading to confounded results. To improve control and
management of malaria as well of iron deficiency, reliable data
about the influence of iron status on malaria risk are needed. The
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aim of this study was to assess the predictive value of baseline iron
status in children for subsequent malaria risk, explicitly taking
misclassification of iron deficiency due to concurrent inflammation
and confounding bias into account by utilizing modern causal
inference methods in the analyses of a dataset of Malawian pre-
school children.
Methods
Study Design
This is a secondary analysis of follow-up data from a cohort of
pre-school children recruited as the control group for the Severe
Anemia Study (SevAna study), a large case-control study investigating
the etiology, pathophysiology and outcome of severe anemia in
southern Malawi [22–24]. The analysis is restricted to the non-
severely anemic control population (hemoglobin level $5.0 g/dL),
because the cases all received a blood transfusion. Follow-up data
of the first year after enrolment were used, allowing the
observation of a full year of malaria transmission per child.
Ethical Statement
The SevAna study was approved by the Ethics Committees of the
College of Medicine, Malawi (ref. no P.00/01/116, and the
Liverpool School of Tropical Medicine, United Kingdom (ref. no
01.29). Prior to enrolment in the study, written informed consent
was obtained from the parent or guardian of all study participants.
Study population
The SevAna study recruited 381 cases and 757 controls between
July 2002 and July 2004 (Figure S1). Every child (6–60 months old)
presenting at the hospital with severe anemia (hemoglobin
,5.0 g/dL) was defined as a case. For each case, two controls
were enrolled; a community control living within 100–1000 meter
of the case, and a hospital control, which was the first child
presenting at the outpatient department on the day following
presentation of the case patient. Controls were eligible for
recruitment if aged 6–60 months and if their hemoglobin level
was at least 5.0 g/dL. All children were visited at 1, 3, 6 and 12
months from date of recruitment (active follow-up). If children did
not report for follow up, families were visited by the study team. In
addition, guardians were asked to present their child to a study-
clinic whenever the child was sick (passive follow-up).
Study setting
The SevAna study took place in Malawi, a land-locked country in
the south-eastern part of Africa of which 20% is covered by Lake
Malawi. The climate is tropical, but prevalence of malaria and
other infectious diseases vary with proximity to the lake and
altitude. Rough estimates of the prevalence of iron deficiency vary
from 20–40% [2,25]. Study participants were recruited in two
settings; Blantyre district (study site: Queen Elizabeth Central
Hospital) and Chikwawa District (study site: Chikwawa District
Hospital), both in the southern region of Malawi. Blantyre is the
main commercial town of Malawi with a predominantly urban
population of half a million. At an altitude of 800 m above sea
level malaria is mainly seasonal (approximately 1 infectious bite
per person per year) [26]. Chikwawa District Hospital, which
caters for a predominantly rural population of approximately 400
thousand people, is situated in the lower Sire Valley, 50 km south
of Blantyre. With an altitude of 250 m above sea level malaria
transmission is year round (approximately 170 infectious bites per
person per year) (Milahowa T, personal communication).
Clinical procedures
At recruitment a detailed medical and socio-economic history
was recorded and a physical examination was performed. Samples
of blood, stool and urine were collected. Children were treated if
indicated using local treatment guidelines. Clinical malaria was
defined as a positive blood slide with concurrent fever (axillary
temp .37.5uC) or history of fever (caregiver recall of fever in the
last week). Severe malaria was defined as a positive blood slide
with either severe anemia (hemoglobin ,5.0 g/dl) or coma [27].
Malaria was treated with sulfadoxine-pyrimethamine (SP) and if
the child was unable to take oral medication parenteral quinine
was administered. As a standard procedure at recruitment all study
participants received presumptive malaria treatment (25.0/
1.25 mg/kg SP) and according to local guidelines all children
received iron supplementation 2 mg/kg/day for 28 days. Follow-
up procedures existed of a medical history, physical examination
and a blood sample to determine hemoglobin and malaria
parasitemia, and if indicated children were treated using local
treatment guidelines. Deaths were recorded and if they occurred
outside the study clinics they were investigated as completely as
possible using a verbal autopsy form.
Laboratory procedures
Hemoglobin (Hb) concentrations were measured by HemoCue
B-Hemoglobin analyzer (HemoCue, A¨ngelholm, Sweden) to judge
eligibility-criteria. Hb measured by Coulter counter analyzer
(Beckman Coulter, Durban, South Africa) was used for statistical
analyses. Moderate and severe anemia were defined as an Hb of
,11.0 g/dL and ,5.0 g/dL, respectively. Plasma levels of C-
reactive protein (CRP) and serum ferritin were analyzed on
Modular P800 and Monular Analytic E170 systems (Roche
Diagnostics, Switzerland). Iron deficiency was defined as serum
ferritin ,30 mg/L [25]. Inflammation was defined as CRP.10 g/
L. For malaria diagnoses thin-film blood slides were read by two
independent readers; with a third reader being used if results
differed by 25% or more. The number of Plasmodium falciparum
asexual parasites per 200 white cells was counted and expressed as
the number per microliter of blood. Malaria parasitemia was
defined as the presence of one or more Pl. falciparum asexual
parasites [28]. Human immunodeficiency virus (HIV) infection
was assessed using two rapid tests (Determine, Abbott Laborato-
ries; and Uni-Gold, Trinity Biotech). Discordant or reactive rapid-
test results in children less than 18 months of age were resolved by
PCR [29].
Statistical Analyses
The incidence of clinical malaria and parasitemia was
calculated for a follow-up period of one year. Multiple events
per child were registered. A child was considered not to be at risk
for incident malaria for the 28 days following malaria treatment
(SP), as the prophylactic effect of malaria treatment was assumed
[30]. This 28 day period was excluded as person-time and malaria
events during this period were not counted for analyses. Malaria
parasitemia or clinical malaria occurring during this period were
defined as treatment-failure and were excluded from analysis.
The main predictor, iron deficiency, was defined as serum
ferritin ,30 mg/L. Possible confounders considered for inclusion
were: sex, age, area of residence, season, socio economic status,
genetic predisposition of malaria, cellular immunity, humoral
immunity, cumulative malaria exposure, malaria immunity,
history of other infections than malaria, HIV infection, hookworm
infection, nutritional status and zinc deficiency (figure 1). We used
DAGittyH, a web-based application based on the Directed Acyclic
Graph theory, to model the causal relationship between iron status,
Iron Status and Malaria Risk
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malaria risk and any potential (measured and unmeasured)
confounders [31,32]. This DAG-program was used to identify
sets of confounders that together fully adjust for confounding in
multivariable modeling [31,33,34]. Several of these sets of
confounders (minimally sufficient adjustment sets) were identified from
figure 1. The set containing HIV-status, socio economic status,
age, nutritional status and study site was used for analysis, as these
variables were available in our data set. Socio economic status was
scored on parents’ education (1–4), job (1–4) and number of assets
(0–6). Chronic malnutrition defined as height-for-age ,22 SD
was used as the marker for nutritional status [35].
Due to inadequate sample volume in 29% of the children serum
ferritin was not available. The missing data were assumed to be
missing at random; basic characteristics between children with and
without available ferritin assessments were comparable (Table S1).
Because complete-cases analysis with a large amount of missing
values may lead to loss of efficiency and bias [36], missing data
were imputed using multiple imputation by chained equations in
the R software version 2.14.0 utilizing the MICE package [37,38].
The imputation model included all baseline covariates in table 1
plus soluble transferrin receptor (sTfR) and mean corpuscular
hemoglobin concentration (MCHC) as additional markers of iron
status. The outcome variable was included in the imputation
model via the event indicator and the Nelson-Aalen estimator of
baseline hazard, as studies suggest that these specific components
lead to lower bias in estimation [39]. Regression estimates and
their standard errors from analyses of the 25 separate imputed
data sets were summarized using Rubin’s rules [40].
To compare the incidence of malaria during follow-up between
iron deficient and iron replete individuals, a marginal structural
Cox proportional hazards model was used to adjust for
confounding. Marginal structural models are a new class of
statistical models to estimate causal effects [41,42], and are
equivalent to non-parametric multivariate standardization meth-
ods [41,43,44]. Effect estimates can be adjusted for measured
confounders using inverse probability of exposure weighting. In
addition, marginal structural models allow the quantitative
evaluation of unmeasured confounding [42,45,46]. Stabilized
inverse probability weights were estimated using the ‘ipw’ package
in R [30,47]. To adjust for the correlation between recurrent
malaria events in a single person, robust standard errors were
computed. All covariates were treated as time-independent. The
proportional hazards assumption was checked by plotting the
scaled Schoenfeld residuals against time and tested using cox.zph
Figure 1. Directed acyclic graph for the relation between iron deficiency and malaria risk. cell. immun: cellular immunity; cum exp:
cumulative malaria exposure; genetic predisp: genetic predisposition; humor immun: humoral immunity; hookw: hookworm infection; hist infect:
history of other infections than malaria; HIV: human immunodeficiency virus; ID: iron deficiency; Pl.f.immun: immunity for Pl.falciparum; Pl.f:
Plasmodium falciparum infection; SE: socio economic score; ZD: zinc deficiency; z.h.a: z-score height for age.
doi:10.1371/journal.pone.0042670.g001
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procedure in R [48]. We assessed whether the effect of iron
deficiency on malaria was modified by age or study site by testing
their interaction terms with the Wald statistic. Interaction terms
were considered significant if p,0.1.
We assessed to which extent the outcomes could have been
biased because of possible misclassification of the iron deficiency
indicator (serum ferritin), by reanalyzing the data using a more
sensitive and a more specific definition of iron deficiency [49]; cut-
offs for serum ferritin that varied by inflammation status; children
without inflammation (CRP,10 g/L) were defined as iron
deficient having a serum ferritin of ,12 mg/L; for children with
current inflammation (CRP.10 g/L) serum ferritin cut-offs of 30
and 70 mg/L were explored [25,50].
In addition, to evaluate how large the average difference in
susceptibility to malaria at baseline between the iron deficient and
iron-replete group would need to have been to partly or fully
explain our observed differences in malaria incidence, we used a
method for sensitivity analysis for unmeasured confounding
developed by Robins et al. [42,45,46]. The method requires that
unmeasured confounding is quantified as a bias parameter
u = a(26ID - 1), with ID= 1 or 0 as indicator of iron deficiency
and a the degree of unmeasured confounding or, in other words,
the average difference in malaria risk at baseline on a ratio-scale
and conditional on the covariate distribution.
Results
Study population
Follow-up data were available for 96.0% of all study partic-
ipants (727/757). Baseline characteristics are presented in table 1.
Baseline characteristics of children with and without follow up
data were comparable (data not shown). Of the remaining 727
children the attendance at active follow-up visits ranged from 86–
89%.
Incidence of malaria parasitemia and clinical malaria
During the follow-up year the overall incidence of malaria
parasitemia and clinical malaria was 1.9 (95% CI 1.8–2.0) and 0.7
(95% CI 0.6–0.8), respectively. This incidence was higher in the
rural areas and in the children less than 24 months of age (Table 2).
There were four cases of severe malaria, three of which were iron
replete. During follow-up 0.7% (1/141) of the iron deficient
children and 1.3% (5/372) of iron replete children died.
Baseline iron status and incidence of malaria
The marginal structural Cox model showed that iron deficiency
was an independent predictor of malaria parasitemia and clinical
malaria; HR (95%CI) 0.55 (0.41–0.74) and 0.49 (0.33–0.73)
respectively (Table 3). The effect of iron deficiency on malaria
parasitemia and clinical malaria was consistent across different
sub-populations; no significant effect measure modification by
study site (urban vs. rural) or age (linear term) was seen (all p-
values.0.9). In addition, the effects were sustained throughout the
study period; the proportional hazards assumption was not refuted
and when analysis was done on consecutive periods of 4 months,
consistent effect measures were seen (data not shown). Analyses
conducted with the complete cases data set (including only
children with a ferritin result) showed comparable results (HR
(95%CI) 0.61 (0.44–0.81) and HR (95%CI) 0.53 (0.36–0.78) for
malaria parasitemia and clinical malaria respectively.
Sensitivity analyses
Analyses assessing sensitivity to misclassification of iron status
are presented in Table 3 and show consistent results using different
definitions of iron deficiency. Hazard ratio estimates for clinical
malaria from the marginal structural Cox model including
adjustment for varying amounts of potential unmeasured con-
founding are presented in Figure 2. Two distinct distributions of
unmeasured confounding were considered. Figure 2a presents
results from analyses in which the net amount of bias per group is
specified. The a priori clinical malaria risk in the iron deficient
group should have been at least 0.72 times the a priori risk in the
iron replete group to remove significance of our findings, and 0.48
times to fully explain our findings (Figure 2a). Figure 2b presents
results from analyses in which the amount of unmeasured
confounding varied as function of age; increasing log-linearly up
to a peak at the age of 3 years and then decreasing to no
confounding effect. The ratio of priori risks would have to have
been at least 0.49 at its peak at 3 years-of-age to remove
significance and 0.18 to fully explain our finding (Figure 2b).
Baseline malaria is often included as a proximate measure of
susceptibility to malaria in multivariable analyses. However, since
our hypothesis was that baseline iron status influences malaria risk,
baseline malaria would technically not be a confounder, i.e. the
exposure may not affect the confounder (Causal knowledge as a
prerequisite for confounding evaluation [33]). We therefore chose
to assess the effect of differences in malaria susceptibility at
baseline through sensitivity analysis. Notwithstanding, when
baseline malaria parasitemia respectively clinical malaria was
included, effect estimates were slightly attenuated though still
significant HR (95%CI) 0.66 (0.48–0.91) and HR (95%CI) 0.51
(0.33–0.79) for malaria parasitemia and clinical malaria respec-
tively.
Discussion
In this study, children with iron deficiency at baseline (serum
ferritin ,30 mg/L) had a lower incidence of malaria parasitemia
and clinical malaria during a follow up period of one year. This
Table 1. Baseline characteristics of the study population.
Characteristic Result
Female 357/727 (49.1%)
Age in months: mean (s.d) 23.9 (12.6)
Age,2 years 408/727 (56.1%)
Living in an urban area 376/727 (51.7%)
SE-score: mean (s.d) 7.2 (2.1)
Hospital control 357/727 (49.1%)
Hemoglobin: mean (s.d) 9.7 (2.1)
Iron deficiency 146/513 (28.5%)
Malnourished 275/669 (41.1%)
Fever (.37.5uC axillary) 205/727 (28.4%)
CRP.10 mg/L 373/630 (59.2%)
Malaria parasitemia 308/720 (42.8%)
Clinical malaria 108/720 (14.9%)
HIV-infected 39/670 (5.8%)
Hemoglobin in g/dl; CRP: C-Reactive Protein; malnourished defined as height-
for-age ,22 SD. HIV: Human Immunodeficiency Virus. Iron deficiency defined
as serum ferritin ,30 ug/L. SE-score: Socio Economic Score, a sum of the
following scores: parents’ education (1–4), job parents (1–4) and number of
assets (0–6).
doi:10.1371/journal.pone.0042670.t001
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finding suggests that iron deficiency protects against malaria
parasitemia and clinical malaria in pre-school children living in
malaria endemic areas. The results were consistent across study
sites with varying transmission intensity and across age-groups
despite changing susceptibility with age. In addition, the difference
in risk between baseline iron status groups persisted throughout
the follow-up period.
Our findings are in line with results of the few other studies
assessing influence of iron status on malaria risk [10,51]. The
protective effects of iron deficiency on malaria risk shown in these
two studies, were of similar magnitude, yet Gwamaka et al also
showed an effect on all cause and malaria associated mortality
[51].
As with any observational study, the results of this study are
subject to bias. Therefore, we explicitly evaluated the potential
impact that misclassification and confounding bias could have had
on our results. Firstly, because serum ferritin levels are influenced
by concurrent inflammation it may not adequately reflect true iron
status. As a consequence, misclassification of baseline iron status
may have occurred and thus resulted in biased effect measures. We
evaluated whether use of a more sensitive and a more specific
definition, taking concurrent inflammation into account, would
substantially change the results. As expected, use of a more specific
definition slightly increased the magnitude of effect and the use of
a more sensitive definition led to a slightly weaker effect.
Importantly, this did not change our conclusions, suggesting that
the findings are robust to misclassification bias.
In the directed acyclic graph (DAG) in Figure 1 all potential
confounders of the effect of iron status on malaria risk as
conceptualized by the authors, were evaluated. We considered two
additional yet unmeasured variables which could theoretically
confound our results by both protecting against malaria and
causing iron deficiency. We assessed how strong these potential
confounding effects should have been to explain the observed
difference in malaria risk between iron status groups. The first
unmeasured factor was ‘cumulative exposure to malaria’. Recent
studies have suggested that chronic infection, including malaria,
may reduce iron absorption in the gut by inducing an increase of
hepcidin [52–54] and that malaria infection may lead to iron loss
through hemosiderin deposition. In addition, repeated malaria
infections (cumulative exposure) result in development of immu-
nity to malaria. The age at which clinical immunity is attained is
influenced by local infection pressure represented by the number
of infectious bites per year (EIR) [55]. If it is true that increased
exposure to malaria simultaneously induces iron deficiency and
increased malaria immunity, cumulative exposure is a potential
confounder in our analyses. In other words, the lower incidence of
malaria in the iron deficient group may have been due to higher
malaria exposure and subsequently better immunity to malaria,
rather than directly due to mechanisms involving iron status. We
conducted sensitivity analyses allowing unmeasured confounding
Table 2. Incidence of malaria parasitemia and clinical malaria per person year.
All Iron deficient group Iron replete group
Events Incidence Events Incidence Events Incidence
Malaria parasitemia All 896 1,9 180 1,3 716 2,2
Urban 253 1,0 38 0,5 215 1,1
Rural 643 3,1 142 2,2 501 3,6
Age,24 months 557 2,1 139 1,4 418 2,5
Age$24 months 339 1,6 41 0,9 298 1,8
Clinical malaria All 318 0,7 58 0,4 260 0,8
Urban 65 0,2 11 0,1 54 0,3
Rural 253 1,2 47 0,7 206 1,5
Age,24 months 207 0,8 44 0,5 163 1,0
Age$24 months 111 0,5 14 0,3 97 0,6
Incidence of malaria parasitemia and clinical malaria per person year stratified per area, age group and iron status. Malaria parasitemia defined as a positive malaria
blood slide; Clinical malaria: positive malaria blood slide with concurrent fever (axillary temp .37.5uC) or history of fever.
doi:10.1371/journal.pone.0042670.t002
Table 3. Hazard ratios (95% Cl) of iron deficiency for the risk on malaria parasitemia en clinical malaria.
univariate Cox model marginal-structural Cox model
Malaria parasitemia Clinical malaria Malaria parasitemia Clinical malaria
Definition iron deficiency HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
SF,30 0.59 (0.44–0.78) 0.54 (0.36–0.80) 0.55 (0.41–0.74) 0.49 (0.33–0.73)
SF,30(CRP.10)/SF,12(CRP,10) 0.57 (0.40–0.82) 0.53 (0.32–0.89) 0.46 (0.31–0.71) 0.43 (0.25–0.73)
SF,70(CRP.10)/SF,12(CRP,10) 0.66 (0.52–0.85) 0.59 (0.41–0.84) 0.60 (0.46–0.79) 0.52 (0.35–0.75)
Iron deficiency is defined with different cut-offs for serum ferritin (SF) in ug/L, depending on presence of inflammation, defined as C-reactive protein (CRP) .10 mg/L.
The marginal-structural Cox model included HIV-infection, socio economic score, age, nutrition and study site.
doi:10.1371/journal.pone.0042670.t003
Iron Status and Malaria Risk
PLOS ONE | www.plosone.org 5 August 2012 | Volume 7 | Issue 8 | e42670
bias to vary as a function of age; reflecting the theoretical
confounding effect of cumulative exposure, where the difference in
immunity (and thus the maximum prior risk difference) gradually
changes with increasing age, reaching a peak at the age of 36
months [56] to subsequently decrease after that. The average prior
risk of malaria should then have been at least half the risk in the
iron replete group at the peak age of 36 months to have led to a
spurious significant finding (Figure 2b). Although theoretically a
plausible confounder, it is unlikely that in reality ‘cumulative
exposure to malaria’ would result in such large differences in prior
malaria risk, suggesting that our measured effects are unlikely due
to confounding by differences in cumulative exposure. As a second
potential confounding factor we considered a (yet undiscovered)
genotype simultaneously causing iron deficiency and increasing
immunity to malaria, for example a variant in iron metabolism
that inhibits maturation of Plasmodium in the red cells [57]. Our
analysis showed that to be responsible for our statistically
significant finding, the average prior risk of malaria in the iron
deficient group should have been at least 0.72 times the risk
compared to that of the iron replete group (Figure 2a). A genetic
predisposition causing a 28% lower prior risk is imaginable (i.e.
sickle cell trait) and if such a genotype is discovered this may
change the interpretation of our results.
In the interpretation of our analyses we assume that iron status
measured at baseline remained relatively stable throughout the
year of follow-up. Unfortunately, iron status measurements were
not repeated after baseline, so we are not able to check this
assumption. It is possible that children changed from the iron
deficient group to the iron replete group and vice versa. However,
because our study population was closely followed and adequately
treated for infections it is more likely that iron deficient children
became iron replete than the other way around. The resulting
misclassification would have resulted in an underestimation of the
effect.
For the underlying mechanism of the protective effect of iron
deficiency on susceptibility to malaria infection, several hypotheses
have been raised. It is suggested that iron deficiency alters the
membrane structure of parasitized erythrocytes which facilitates
their elimination by phagocytic cells, yet further research is needed
to further support this hypothesis [58]. Another hypothesis is that
the increased zinc protoporphyrin in iron deficient parasitized red
blood cells binds to heme crystals and thus inhibits the formation
of hemozoin, in analogue to antimalarial quinolines [59].
We cannot fully exclude that the observed effect was the result
of increased susceptibility in the iron replete group resulting from
the month of iron supplementation, rather than a protective effect
of iron deficiency. In 2006 a large supplementation trial in
Zanzibar was stopped prematurely after increased morbidity and
mortality was observed in iron replete children receiving iron and
folic acid [19]. However it remains unclear whether the increased
morbidity was due to the effect of the iron, or the folic acid
component of the supplements [60,61]. Although the month of
iron supplementation in this study complicates the interpretation
of our study results, it is a reflection of current practice in this such
settings in which short courses if iron supplementation are
routinely given. In addition we think its influence was minimal
for several reasons. Firstly, since the difference in risk was still
observable towards the end of follow-up, the influence of the one
month of iron supplementation was likely to be negligible.
Secondly 59% of the children had an infection at baseline and
this was likely to inhibit the absorption of iron in the first two
weeks of supplementation [52–54].
In conclusion, iron deficiency seems to protect against malaria
parasitemia and clinical malaria. However, because we lack direct
measures of baseline immunity to malaria our results should be
confirmed by well conducted randomized controlled trials or
observational birth cohort studies. Our findings support the theory
of nutritional adaptation to infectious diseases [62,63]. To avoid
Figure 2. Sensitivity analysis of the impact of unmeasured confounding on the effect of baseline iron deficiency on risk of clinical
malaria. The y-axis represents the hazard ratio for malaria infection comparing iron deficiency to iron replete after adjustment for average
differences in prior risk represented by a on the x-axis. Figure 2a represents analyses in which net amount of confounding is specified for both iron
status groups (bias parameter u =a(26ID - 1)). Figure 2b represents analyses in which the amount of confounding was varied as a function of age (bias
parameter u =a(26ID - 1)6(1 - abs(age-36)/30).
doi:10.1371/journal.pone.0042670.g002
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increased malaria risk due to ‘‘neutralizing’’ the protective effect of
iron deficiency, treatment of iron deficiency should occur under
simultaneous and sustained control of prevalent infections. We
recommend that treatment of iron deficiency occurs within the
context of the Integrated Management of Childhood Illness
(IMCI) and will benefit from the addition of Integrated Vector
Management (IVM) [64,65]. However, because oral iron is often
poorly absorbed in individuals with concurrent inflammation [52–
54], prevention of iron deficiency may be more effective.
Treatment and especially prevention of infections, in particular
hookworm infections [4,66], will contribute to prevention of iron
deficiency through decreased loss and increased absorption of
dietary iron. Whichever strategy is chosen, concurrent and
sustained prevention of malaria through Integrated Management
of Childhood Illness is imperative in malaria endemic areas.
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